openPR Logo
Press release

Bacterial Nanocellulose Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

08-13-2024 09:30 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Bacterial Nanocellulose Market

Due to the COVID-19 pandemic, the global Bacterial Nanocellulose market size is estimated to be worth USD 209.7 Million in 2022 and is forecast to a readjusted size of USD 269.9 Million by 2028 with a CAGR of 4.3% during the review period.

View Sample Report
https://reports.valuates.com/request/sample/QYRE-Auto-2U7391/Global_Bacterial_Nanocellulose_Market_Insights_and_Forecast_to_2028

Report Scope
Bacterial cellulose (BC) refers to a kind of bacteria belonging to the genus Acetobacter, Agrobacterium, Rhizobium and Sarcina under different conditions. A general term for cellulose synthesized by microorganisms.
Fully considering the economic change by this health crisis, Nanofibrillated Cellulose accounting for % of the Bacterial Nanocellulose global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.
While Composites segment is altered to an % CAGR throughout this forecast period.
Some bacterial cellulose is concentrated in food, food additives and papermaking applications, and only stays in low-end products in the development and application of biomedical materials.
In terms of production side, this report researches the Bacterial Nanocellulose capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Bacterial Nanocellulose by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Bacterial Nanocellulose market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bacterial Nanocellulose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Get Regional Report
https://reports.valuates.com/request/regional/QYRE-Auto-2U7391/Global_Bacterial_Nanocellulose_Market_Insights_and_Forecast_to_2028

Segment by Type
• Nanofibrillated Cellulose
• Nanocrystalline Cellulose

Segment by Application
• Composites
• Paper Processing
• Food & Beverages
• Paints & Coatings
• Oil & Gas
• Personal Care
• Other End-users

By Companies
• Fiberlean
• Kruger
• Borregaard
• Paperlogic
• Nippon Paper
• Celluforce
• University of Maine
• American Process
• Oji Paper
• Inventia

View Full Report
https://reports.valuates.com/market-reports/QYRE-Auto-2U7391/global-bacterial-nanocellulose

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Nanocellulose Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports here

News-ID: 3621090 • Views:

More Releases from Valuates Reports

Asynchronous Dual-Port DRAM Market Share Driven by High-Speed Data Access and Pa …
Asynchronous Dual-Port DRAM Market Size The global market for Asynchronous Dual-Port DRAM was valued at US$ 374 million in the year 2024 and is projected to reach a revised size of US$ 537 million by 2031, growing at a CAGR of 5.3% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-14L20033/Global_Asynchronous_Dual_Port_DRAM_Market_Research_Report_2025 The Asynchronous Dual-Port DRAM Market is gaining steady market growth as industries increasingly rely on memory solutions that support simultaneous read and write operations
β-Nicotinamide Mononucleotide (NMN) Market Share Driven by Expanding Health Sup …
β-Nicotinamide Mononucleotide (NMN) Market Size The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-16K9169/Global_%CE%B2_Nicotinamide_Mononucleotide_NMN_Market_Insights_and_Forecast_to_2028 The β-Nicotinamide Mononucleotide (NMN) Market is experiencing notable market growth as interest in cellular health, healthy aging, and metabolic support continues to rise across
Aluminium Foil Market Share Driven by Packaging Demand, Energy Efficiency, and E …
Aluminium Foil - Market Size The global market for Aluminium Foil was estimated to be worth US$ 21620 million in 2023 and is forecast to a readjusted size of US$ 29320 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030 View sample report https://reports.valuates.com/request/sample/QYRE-Auto-4P1801/Global_Aluminium_Foil_Market_Insights_and_Forecast_to_2028 The Aluminium Foil Market continues to demonstrate resilient market growth, supported by its essential role across packaging, thermal management, and advanced electrical applications. Market trends reflect
DNA Data Storage Market Share Driven by Exponential Data Generation and Advances …
DNA Data Storage Market The global market for DNA Data Storage was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-29Y8377/Global_DNA_Data_Storage_Market_Insights_Forecast_to_2028 The DNA Data Storage Market is emerging as a transformative solution for long-term, high-density data preservation, driven by the rapid growth of digital information and limitations of

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as